12 completed, 2 unknown, 2 withdrawn, 1 terminated. 17 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 12, Unknown 2, Withdrawn 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Iron: new trials by email Literature Review of Iron trials Research Report on Iron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria. intravenous iron, oral iron - Postpartum Anaemia | Phase 1 / Phase 2 | Completed | Federal Teaching Hospital Abakaliki | 290 | 2018-09-13 | 2025-08-08 |
| Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial Epoetin Alfa and Iron, Iron - Cyanotic Congenital Heart Disease, Anemia | Phase 2 | Terminated | University of California, San Diego | 4 | 2016-11-01 | 2021-12-02 |
| Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement Iron - Prevention of Anemia | Phase 1 / Phase 2 | Completed | Hippocration General Hospital | 50 | 2016-11-01 | 2020-07-29 |
| Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis Placebo, Iron 150 mg and Folic acid 0.5 mg - Chronic Arsenic Poisoning | Phase 2 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 42 | 2016-06-01 | 2017-07-13 |
| Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA) Ferumoxytol intravenous, Ferrous sulfate - Restless Legs Syndrome, Iron Deficiency Anemia | Phase 2 | Completed | Auerbach Hematology Oncology Associates P C | 100 | 2014-08-01 | 2024-01-30 |
| Safe and Efficacious Iron for Children in Kenya Low-dose iron as NaFeEDTA, Conventional dose iron as ferrous salt, Placebo - Anaemia | Phase 2 / Phase 3 | Completed | London School of Hygiene and Tropical Medicine | 338 | 2014-06-01 | 2015-04-10 |
| Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease PT20, Placebo - Hyperphosphataemia | Phase 2 | Completed | Phosphate Therapeutics | 153 | 2014-05-07 | 2018-01-16 |
| Fermented Iron-rich Supplement in Reducing Anemia supplement containing 60 mg iron sulfate, iron rich food supplement (60 mg iron), iron rich food supplement (10 mg iron) - Iron Deficiency Anemia | Phase 2 | Unknown | University of Ghana | 120 | 2014-03-01 | 2014-01-16 |
| The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients Jobelyn, Ferrous Sulphate + Folic Acid - Anemia | Phase 2 | Completed | Lagos State University | 73 | 2012-12-01 | 2016-05-18 |
| Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease Growth Hormone, Nutraceutical Combination, Exclusion Diet - Crohn's Disease | Phase 2 | Withdrawn | Columbia University | 2012-03-01 | 2015-04-13 | |
| Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls Iron, Folic acid and Cyanocobalamin, Iron and Folic Acid - Anaemia | Phase 2 | Unknown | Indian Council of Medical Research | 360 | 2012-01-01 | 2012-02-28 |
| Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment Roxadustat, Oral Iron, IV Iron - Dialysis, Anemia | Phase 2 | Completed | Kyntra Bio | 60 | 2011-07-21 | 2021-10-01 |
| Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients Soluble Ferric Pyrophosphate in liquid bicarbonate, Placebo: Conventional liquid bicarbonate, Erythrocyte Stimulating Agent (ESA) - End Stage Renal Disease | Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 108 | 2011-01-01 | 2018-10-01 |
| Study of Phosphate Levels in Patients With Chronic Kidney Disease 1.25 g PA21 (250 mg iron), 5.0 g PA21 (1,000 mg iron), 7.5 g PA21 (1,500 mg iron) - Chronic Kidney Disease | Phase 2 | Completed | Vifor Pharma | 154 | 2008-12-01 | 2014-04-01 |
| Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia Epoetin Alfa plus Iron - Anemia | Phase 2 | Withdrawn | University of Louisville | 2007-05-01 | 2018-03-05 | |
| Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation Thalidomide, Iron - Obscure Gastrointestinal Bleeding, Angiodysplasia | Phase 2 | Completed | Shanghai Jiao Tong University School of Medicine | 55 | 2004-11-01 | 2015-12-17 |
| 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients. Sodium Ferric Gluconate Complex, Oral Iron - Iron Deficiency Anemia | Phase 2 / Phase 3 | Completed | Watson Pharmaceuticals | 146 | 2003-12-01 | 2013-07-08 |
Anemia (7) · Anemia, Iron-Deficiency (3) · Kidney Failure, Chronic (2) · Angiodysplasia (1) · Crohn Disease (1) · Cyanosis (1) · Gastric Antral Vascular Ectasia (1) · Gastrointestinal Hemorrhage (1) · Heart Defects, Congenital (1) · Hyperphosphatemia (1) · Inflammatory Bowel Diseases (1) · Renal Insufficiency, Chronic (1) · Restless Legs Syndrome (1) · Vascular Malformations (1)
Auerbach Hematology Oncology Associates P C (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Columbia University (1) · Federal Teaching Hospital Abakaliki (1) · Hippocration General Hospital (1) · Indian Council of Medical Research (1) · Kyntra Bio (1) · Lagos State University (1) · London School of Hygiene and Tropical Medicine (1) · Phosphate Therapeutics (1) · Rockwell Medical Technologies, Inc. (1) · Shanghai Jiao Tong University School of Medicine (1) · University of California, San Diego (1) · University of Ghana (1) · University of Louisville (1)
United States (8) · Russia (3) · Bulgaria (2) · Croatia (2) · India (2) · Nigeria (2) · Poland (2) · Bangladesh (1) · Canada (1) · Czechia (1) · Germany (1) · Hong Kong (1) · Kenya (1) · Mexico (1) · Puerto Rico (1)
Adetokunbo O Tayo, M.D. (1) · Alfred E Slonim, MD (1) · David K Werho, MD (1) · Dr. Anupa Siddhu, Ph.D (1) · Dr. Gurdayal S Toteja, Ph.D (1) · Dr. Naval K Vikram, M.D. (1) · Dr. Neena Bhatia, Ph.D (1) · Gary Hoel, RPh, PhD (1) · Geoff Block, MD (1) · Goetz H Kloecker, MD (1) · Hans Verhoef, PhD (1) · Manju Reddy, PhD (1) · Michael Auerbach, MD (1) · Mir Misbahuddin, PhD (1)
PMID 40576086, PMID 26154926, PMID 28449690, PMID 28770094, PMID 29391008, PMID 32651955, PMID 36005278